Parabolic Drugs has received European GMP Certifications for its Works Site located at Derabassi for manufacture of Cephalosporin products and at Lalru for manufacture of Non-beta Lactams products.
Parabolic Drugs (PDL) has commenced its commercial operations in 1998 with contract manufacturing of APIs and API intermediates for sales in India and abroad (including regulated markets). PDL presently has four facilities comprising of three manufacturing plants, viz, Derabassi and Chachrauli (both Punjab) and Panchkula and an R&D centre at Barwala (both Haryana).
